Pustular psoriasis in a patient with astrocytoma
DOI:
https://doi.org/10.47196/da.v31i3.2967Keywords:
pustular psoriasis, astrocytoma, central nervous system tumorsAbstract
Pustular psoriasis is a rare and clinically challenging form of psoriasis, as its diagnosis and treatment can be complex due to its unusual presentation and the possibility of associations with other pathologies. An uncommon relationship between pustular psoriasis and central nervous system tumors has been observed; however, to date, no publications have been found describing its association with astrocytoma. Astrocytoma is a central nervous system tumor that develops from cells called astrocytes. This association may represent a diagnostic challenge due to the possibility of atypical cutaneous manifestations in patients with underlying neurological pathology, as well as a therapeutic challenge requiring a coordinated approach for the management of both conditions. We present the case of a 40-year-old female patient who developed pustular psoriasis in the context of a grade IV pilocytic astrocytoma. The clinical manifestations and the treatment strategies used in this context are discussed.
References
I. Menter AS, Van Voorhees A, Hsu S. Pustular psoriasis. A narrative review of recent developments in pathophysiology and therapeutic options. Dermatol Ther (Heidelb). 2021;11:1917-1929.
II. Pizzimenti C, Fiorentino V, Germanò A, Martini M, et ál. Pilocytic astrocytoma. The paradigmatic entity in low-grade gliomas. Oncol Lett. 2024;27:146.
III. Nast A, Smith C, Spuls PI, Ávila G, et ál. EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris. Part 2: Specific clinical and comorbid situations. J Eur Acad Dermatol Venereol. 2021;35:281-317.
IV. Robinson AS, Van Voorhees A, Hsu S, Korman N, et ál. Treatment of pustular psoriasis: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2012; 67:279-288.
V. Puig L, Notario J, López-Ferrer A, Scheneller-Pavelescu L, et ál. Recomendaciones del Grupo de Psoriasis de la Academia Española de Dermatología y Venereología sobre el manejo de la psoriasis en pacientes oncológicos. Actas Dermosifiliogr. 2024;1-10.
VI. Fujita H, Terui T, Hayama K, Akiyama M, et ál. Japanese guidelines for the management and treatment of generalized pustular psoriasis. The new pathogenesis and treatment of GPP. Journal of Dermatology. 2018;45:1235-1270.
VII. Wu X, Ma Y, Wang L, Qin X. A route for investigating psoriasis: from the perspective of the pathological mechanisms and therapeutic strategies of cancer. Int J Mol Sci. 2023; 24:14390.
VIII. Baum P, Visvanathan S, Garcet S, Bissonnette R, et ál. Pustular psoriasis. Molecular pathways and effects of spesolimab in generalized pustular psoriasis. J Allergy Clin Immunol. 2022;149:1402-1412.
IX. Hawkes JE, Visvanathan S, Krueger JG. The role of the interleukin-36 axis in generalized pustular psoriasis: a review of the mechanism of action of spesolimab. Front Immunol. 2023;14:1292941.
X. Rega F, Trovato F, Bortone G, Pellacani G, et ál. Therapeutic potential of spesolimab-sbzo in the management of generalized pustular psoriasis flares in adults: evidence to date. Psoriasis (Auckl). 2024;14:23-27.
XI. Trafford AM, Parisi R, Kontopantelis E, Griffiths CEM, et ál. Association of psoriasis with the risk of developing or dying of cancer: a systematic review and meta-analysis. JAMA Dermatol. 2019;155:1390-1403.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 on behalf of the authors. Reproduction rights: Argentine Society of Dermatology

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
El/los autor/es tranfieren todos los derechos de autor del manuscrito arriba mencionado a Dermatología Argentina en el caso de que el trabajo sea publicado. El/los autor/es declaran que el artículo es original, que no infringe ningún derecho de propiedad intelectual u otros derechos de terceros, que no se encuentra bajo consideración de otra revista y que no ha sido previamente publicado.
Le solicitamos haga click aquí para imprimir, firmar y enviar por correo postal la transferencia de los derechos de autor






